AN UNBIASED VIEW OF PF-05221304

Cure with SR18662 noticeably cuts down expansion and proliferation of CRC cells. SR18662 displays improved efficacy in decreasing viability of multiple CRC mobile traces. Flow cytometry analysis following SR18662 procedure demonstrates an increase in cells captured in both S or G2/M phases from the mobile cycle and a major rise in the number of apo